| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 1381 |
| 1 | ETONOGESTREL | 743 |
| 2 | COPPER | 220 |
| 3 | TREPROSTINIL | 153 |
| 4 | ASPIRIN | 137 |
| 5 | ASPIRIN 325 MG | 136 |
| 6 | ASPIRIN 81 MG | 136 |
| 7 | ALENDRONATE SODIUM | 129 |
| 8 | SILDENAFIL CITRATE | 128 |
| 9 | TERIPARATIDE | 126 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN IN 5 PERCENT DEXTROSE | 1 | 1.0000 |
| 1 | ALCOHOL PADS | 1 | 0.1667 |
| 2 | ETONOGESTREL | 743 | 0.0129 |
| 3 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 4 | 0.0109 |
| 4 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 22 | 0.0079 |
| 6 | LEVONORGESTREL | 1381 | 0.0068 |
| 7 | COAGULATION FACTOR VIIA (RECOMBINANT) | 14 | 0.0052 |
| 8 | SODIUM NITROPRUSSIDE | 2 | 0.0052 |
| 9 | ESTRADIOL ACETATE | 4 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 2220 |
| 1 | Progestin-containing Intrauterine System [EPC] | 1379 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 280 |
| 3 | Copper-containing Intrauterine Device [EPC] | 221 |
| 4 | Prostacycline Vasodilator [EPC] | 208 |
| 5 | Corticosteroid [EPC] | 179 |
| 6 | Insulin Analog [EPC] | 169 |
| 7 | Benzodiazepine [EPC] | 148 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 140 |
| 9 | Endothelin Receptor Antagonist [EPC] | 131 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lincosamide Antibacterial [EPC] | 1 | 1.0000 |
| 1 | Progestin [EPC] | 2220 | 0.0076 |
| 2 | Copper-containing Intrauterine Device [EPC] | 221 | 0.0045 |
| 3 | Calcitonin [EPC] | 8 | 0.0026 |
| 4 | Vitamin D2 Analog [EPC] | 15 | 0.0021 |
| 5 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 6 | Prostacycline Vasodilator [EPC] | 208 | 0.0015 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 10 | 0.0014 |
| 8 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 9 | Insulin [EPC] | 59 | 0.0013 |